GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Shiller PE Ratio

PEPTONIC medical AB (XSAT:PMED) Shiller PE Ratio : (As of Jun. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


PEPTONIC medical AB Shiller PE Ratio Historical Data

The historical data trend for PEPTONIC medical AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB Shiller PE Ratio Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PEPTONIC medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PEPTONIC medical AB's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PEPTONIC medical AB's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's Shiller PE Ratio falls into.



PEPTONIC medical AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

PEPTONIC medical AB's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, PEPTONIC medical AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.005/132.2054*132.2054
=-0.005

Current CPI (Mar. 2024) = 132.2054.

PEPTONIC medical AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.043 100.432 -0.057
201409 -0.058 100.161 -0.077
201412 -0.077 100.225 -0.102
201503 -0.065 99.950 -0.086
201506 -0.080 99.995 -0.106
201509 -0.048 100.228 -0.063
201512 -0.099 100.276 -0.131
201603 -0.039 100.751 -0.051
201606 -0.028 101.019 -0.037
201609 -0.019 101.138 -0.025
201612 -0.028 102.022 -0.036
201703 -0.027 102.022 -0.035
201706 -0.025 102.752 -0.032
201709 -0.019 103.279 -0.024
201712 -0.030 103.793 -0.038
201803 -0.024 103.962 -0.031
201806 -0.016 104.875 -0.020
201809 -0.016 105.679 -0.020
201812 -0.023 105.912 -0.029
201903 -0.022 105.886 -0.027
201906 -0.028 106.742 -0.035
201909 -0.017 107.214 -0.021
201912 -0.030 107.766 -0.037
202003 -0.019 106.563 -0.024
202006 -0.024 107.498 -0.030
202009 -0.057 107.635 -0.070
202012 -0.029 108.296 -0.035
202103 -0.014 108.360 -0.017
202106 -0.030 108.928 -0.036
202109 -0.024 110.338 -0.029
202112 -0.110 112.486 -0.129
202203 -0.046 114.825 -0.053
202206 -0.031 118.384 -0.035
202209 -0.031 122.296 -0.034
202212 -0.016 126.365 -0.017
202303 -0.006 127.042 -0.006
202306 -0.008 129.407 -0.008
202309 -0.008 130.224 -0.008
202312 -0.010 131.912 -0.010
202403 -0.005 132.205 -0.005

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PEPTONIC medical AB  (XSAT:PMED) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


PEPTONIC medical AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PEPTONIC medical AB (XSAT:PMED) Business Description

Traded in Other Exchanges
Address
Gustavslundsvägen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines